5.34
-0.25
(-4.40%)
As of 10:17:15 AM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Robert C. Andrade | Chief Financial Officer | 600.88k | -- | 1975 |
| Mr. Jeffrey S. Hackman | CEO & Director | -- | -- | 1963 |
| Mr. Terry Evans | Chief Commercial Officer | -- | -- | -- |
| Dr. Pierre S. Sayad M.S., Ph.D. | Chief Medical Officer | -- | -- | -- |
| Ms. Christiana Cioffi M.B.A. | Chief Strategy Officer | -- | -- | -- |
| Mr. Mark Gowland | Controller | -- | -- | -- |
| Mr. Lei Fang | President of Pharstat Inc | -- | -- | -- |
Fennec Pharmaceuticals Inc.
68 TW Alexander Drive
PO Box 13628
Research Triangle Park, NC 27709
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 32
Description
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Corporate Governance
Fennec Pharmaceuticals Inc.’s ISS Governance QualityScore as of April 1, 2025 is 6. The pillar scores are Audit: 9; Board: 5; Shareholder Rights: 5; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 12, 2025 at 12:30 PM UTC - May 19, 2025 at 12:30 PM UTC
Fennec Pharmaceuticals Inc. Earnings Date
Recent Events
Related Tickers
DMAC DiaMedica Therapeutics Inc.
3.5900
-2.45%
SCPH scPharmaceuticals Inc.
2.2201
-3.47%
YMAB Y-mAbs Therapeutics, Inc.
4.4950
-3.54%
JUNS Jupiter Neurosciences, Inc.
0.5651
-10.02%
VRCA Verrica Pharmaceuticals Inc.
0.4040
-3.81%
PYPD PolyPid Ltd.
2.7500
+1.10%
RZLT Rezolute, Inc.
2.5900
-5.47%
GYRE Gyre Therapeutics, Inc.
6.71
-1.32%
ACOG Alpha Cognition Inc.
5.0000
-1.38%
ACHV Achieve Life Sciences, Inc.
2.2765
-5.92%